# US 2026/0062406 A1 · Benzisoxazole Sulfonamide Derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0062406 A1
- Document ID: US20260062406A1
- Status: Published application
- Kind: A1
- Application number: 19/241,666
- Filed: 2025-06-18
- Published: 2026-03-05
- Earliest claimed: 2019-06-18
- Assignees: Pfizer Inc.; Ctxt Pty Ltd
- Applicants: Pfizer Inc.; Ctxt Pty Ltd
- Inventors: Ylva Elisabet Bergman Bozikis; Oleg Brodsky; Michelle Ang Camerino; Samantha Elizabeth Greasley; Robert Louis Hoffman; Robert Arnold Kumpf; Pei-Pei Kung; Paul Francis Richardson; Paul Anthony Stupple; Scott Channing Sutton
- Web page: https://patentgrep.com/patent/US20260062406A1

## CPC

- C07D 413/06: linked by a carbon chain containing only aliphatic carbon atoms
- A61P 35/00: Antineoplastic agents
- A61P 35/04: specific for metastasis
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- C07B 2200/13: Crystalline forms, e.g. polymorphs
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein Ring A, R1-R8, and n are defined herein. The novel benzisoxazole sulfonamide derivatives are useful in the treatment of abnormal cell growth, such as cancer, in patients. Additional embodiments relate to pharmaceutical compositions containing the compounds and to methods of using the compounds and compositions in the treatment of abnormal cell growth in patients.

## Claims

### Claim at position 1

1-26. (canceled)

### Claim 27

A method of treating cancer in a patient comprising administering to the patient an amount of a compound
or a pharmaceutically acceptable salt thereof, wherein the cancer is leukemia.

### Claim at position 3

28-34. (canceled)

### Claim 35 (depends on 27)

The method of claim 27, wherein the leukemia is chronic leukemia.

### Claim 36 (depends on 27)

The method of claim 27, wherein the leukemia is acute leukemia.

### Claim 37 (depends on 27)

The method of claim 27, wherein the leukemia is acute myeloid leukemia.
